Anastin and malignant gliomas:
Gespeichert in:
| Format: | Elektronisch E-Book |
|---|---|
| Sprache: | English |
| Veröffentlicht: |
[Place of publication not identified]
Bentham e Books
[2011]
|
| Schriftenreihe: | Controversies in Neuro-Oncology, 1
|
| Schlagworte: | |
| Online-Zugang: | FAW01 FAW02 |
| Beschreibung: | Includes bibliographical references and indexes 01 Cover Page.pdf; 02 Title Page; 03 eBooks End User License Agreement-Website; 04 table of contents; 05 Foreword; 06 PREFACE-Avastin; 07 Contributors; 08 Part 1 BASIC SCIENCE AND RATIONALE; 09 Ch-1; 10 Part 2; 11 Ch-2 Desjardins-Avastin-recurrent-chen; 12 Ch-3 kreisl-Avastin_and_Mailgnant_Gliomas_-_Is_there_a_role[1]-chen; 13 Ch-4 GutinRT-_bev_review_FI_PG_9-22[1]-chen; 14 Ch-5 norden_controversies_6-19-09[1]-chen; 15 Part 3; 16 Ch-6 Reardon_chapter_8[1].29; 17 Ch-7 Mehta-radiationControversies_in_Neuro-Avastin-final[1]-chen 18 Ch-8 Gilbert-Bevacizumab_and_Malignant_Glioma_final_version_9-14-09[1]-Gilbert-chen19 Part 4; 20 Ch-9 Schiff-Avastin toxicityFinal-Bevacizumab_Toxicity_in_Glioblastoma_with_DS_edits_090109-for_review_11[1]-chen corrected; 21 Ch-10 Rogers Chapter_-_Avastin_and_AC_-_Chamberlain_11-2-09__3_[2]-Chen; 22 Part 5; 23 Ch-11 Raizer- AvastinFinal__2_[1]-chen; 24 Part 6; 25 Ch-12 POPE_GBM_Avastin_Imaging[1]-chen; 26 Ch-13 Butowski-radiographic responses 2-chen; 27 Ch-14 Imaging Responses of Bevacizuma; 28 Ch-15 HENSON091509cleanref[1]-chen; 29 Part 7; 30 Ch-16 Aghi-_Avastin_v2[1]-Chen 31 Ch-17 Vogelbaum-Surgical Implications-Avastin_Final[1]-chen32 Part 8; 33 Ch-18 chamberlain-BevNovelApplications_8_6_09[1]-chen; 34 Ch-19 Levin-Radiation_necrosis-082509-Final[1]-chen; 35 Ch-20 chamberlain-salvage-chen; 36 Part 9; 37 Ch-21 StuppBev_rec_glioma__final[1]-chen; 38 Ch-22 van den Bent-Avastin in Europe-chen; 39 Ch-23 Avastin_Weller_2009-6-30[1]-chen; 40 Ch-24 Wick European pers-chen; 41 Part 10; 42 Ch-25 Sunitinib_ebook_chapter___B_Neyns[1]-chen; 43 Ch-26 nabors-cilengitide-chen; 44 Ch-27 SorafenibChapter_FINAL[2]-chen; 45 Ch-28 Wen-VEGF-trap_8-14-09_FINAL[1]-chen 46 Ch-29 Batchelor-Gerstner-Dietrich-Cediranib-09-12-09[1]-chen47 Part 11 Conclusion; 48 Ch-30 Gu Development_of_Bevacizumab[1][1]-chen; 49 Author Index -Avastin; 50 Index-final-chen Neuro-oncology is an embryonic field of cancer research with a number of clinical trials in progress. However, the prognosis on neuro-oncologic patients has remained poor. Moreover, several small scale phase I/II trials performed have proved to be inconclusive because of the limited number of patients involved. As a result, many controversies exist in neuro-oncology drug development for which a forum does not exist. This ebook presents a detailed account on the use of avastin in treating cancer patients. A discussion on clinical experiences and the controversial debate among researchers of ava |
| Beschreibung: | vii, 195 pages |
| ISBN: | 9781608051328 1608051323 |
Internformat
MARC
| LEADER | 00000nmm a2200000zc 4500 | ||
|---|---|---|---|
| 001 | BV043961047 | ||
| 003 | DE-604 | ||
| 005 | 00000000000000.0 | ||
| 007 | cr|uuu---uuuuu | ||
| 008 | 161213s2011 |||| o||u| ||||||eng d | ||
| 020 | |a 9781608051328 |9 978-1-60805-132-8 | ||
| 020 | |a 1608051323 |9 1-60805-132-3 | ||
| 035 | |a (ZDB-4-EBA)ocn708569317 | ||
| 035 | |a (OCoLC)708569317 | ||
| 035 | |a (DE-599)BVBBV043961047 | ||
| 040 | |a DE-604 |b ger |e aacr | ||
| 041 | 0 | |a eng | |
| 049 | |a DE-1047 |a DE-1046 | ||
| 082 | 0 | |a 616.8 | |
| 245 | 1 | 0 | |a Anastin and malignant gliomas |c editor, Thomas C. Chen ; co-editor, Marc Chamberlain |
| 264 | 1 | |a [Place of publication not identified] |b Bentham e Books |c [2011] | |
| 300 | |a vii, 195 pages | ||
| 336 | |b txt |2 rdacontent | ||
| 337 | |b c |2 rdamedia | ||
| 338 | |b cr |2 rdacarrier | ||
| 490 | 0 | |a Controversies in Neuro-Oncology, 1 | |
| 500 | |a Includes bibliographical references and indexes | ||
| 500 | |a 01 Cover Page.pdf; 02 Title Page; 03 eBooks End User License Agreement-Website; 04 table of contents; 05 Foreword; 06 PREFACE-Avastin; 07 Contributors; 08 Part 1 BASIC SCIENCE AND RATIONALE; 09 Ch-1; 10 Part 2; 11 Ch-2 Desjardins-Avastin-recurrent-chen; 12 Ch-3 kreisl-Avastin_and_Mailgnant_Gliomas_-_Is_there_a_role[1]-chen; 13 Ch-4 GutinRT-_bev_review_FI_PG_9-22[1]-chen; 14 Ch-5 norden_controversies_6-19-09[1]-chen; 15 Part 3; 16 Ch-6 Reardon_chapter_8[1].29; 17 Ch-7 Mehta-radiationControversies_in_Neuro-Avastin-final[1]-chen | ||
| 500 | |a 18 Ch-8 Gilbert-Bevacizumab_and_Malignant_Glioma_final_version_9-14-09[1]-Gilbert-chen19 Part 4; 20 Ch-9 Schiff-Avastin toxicityFinal-Bevacizumab_Toxicity_in_Glioblastoma_with_DS_edits_090109-for_review_11[1]-chen corrected; 21 Ch-10 Rogers Chapter_-_Avastin_and_AC_-_Chamberlain_11-2-09__3_[2]-Chen; 22 Part 5; 23 Ch-11 Raizer- AvastinFinal__2_[1]-chen; 24 Part 6; 25 Ch-12 POPE_GBM_Avastin_Imaging[1]-chen; 26 Ch-13 Butowski-radiographic responses 2-chen; 27 Ch-14 Imaging Responses of Bevacizuma; 28 Ch-15 HENSON091509cleanref[1]-chen; 29 Part 7; 30 Ch-16 Aghi-_Avastin_v2[1]-Chen | ||
| 500 | |a 31 Ch-17 Vogelbaum-Surgical Implications-Avastin_Final[1]-chen32 Part 8; 33 Ch-18 chamberlain-BevNovelApplications_8_6_09[1]-chen; 34 Ch-19 Levin-Radiation_necrosis-082509-Final[1]-chen; 35 Ch-20 chamberlain-salvage-chen; 36 Part 9; 37 Ch-21 StuppBev_rec_glioma__final[1]-chen; 38 Ch-22 van den Bent-Avastin in Europe-chen; 39 Ch-23 Avastin_Weller_2009-6-30[1]-chen; 40 Ch-24 Wick European pers-chen; 41 Part 10; 42 Ch-25 Sunitinib_ebook_chapter___B_Neyns[1]-chen; 43 Ch-26 nabors-cilengitide-chen; 44 Ch-27 SorafenibChapter_FINAL[2]-chen; 45 Ch-28 Wen-VEGF-trap_8-14-09_FINAL[1]-chen | ||
| 500 | |a 46 Ch-29 Batchelor-Gerstner-Dietrich-Cediranib-09-12-09[1]-chen47 Part 11 Conclusion; 48 Ch-30 Gu Development_of_Bevacizumab[1][1]-chen; 49 Author Index -Avastin; 50 Index-final-chen | ||
| 500 | |a Neuro-oncology is an embryonic field of cancer research with a number of clinical trials in progress. However, the prognosis on neuro-oncologic patients has remained poor. Moreover, several small scale phase I/II trials performed have proved to be inconclusive because of the limited number of patients involved. As a result, many controversies exist in neuro-oncology drug development for which a forum does not exist. This ebook presents a detailed account on the use of avastin in treating cancer patients. A discussion on clinical experiences and the controversial debate among researchers of ava | ||
| 650 | 4 | |a Neurology / Miscellanea | |
| 650 | 4 | |a Neurology | |
| 650 | 7 | |a HEALTH & FITNESS / Diseases / Nervous System (incl. Brain) |2 bisacsh | |
| 650 | 7 | |a MEDICAL / Neurology |2 bisacsh | |
| 650 | 7 | |a Bevacizumab |2 fast | |
| 650 | 7 | |a Gliomas |2 fast | |
| 650 | 4 | |a Medizin | |
| 650 | 4 | |a Gliomas | |
| 650 | 4 | |a Bevacizumab | |
| 700 | 1 | |a Chen, Thomas C. |e Sonstige |4 oth | |
| 700 | 1 | |a Chamberlain, Marc C. |e Sonstige |4 oth | |
| 912 | |a ZDB-4-EBA | ||
| 999 | |a oai:aleph.bib-bvb.de:BVB01-029369751 | ||
| 966 | e | |u http://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&AN=500681 |l FAW01 |p ZDB-4-EBA |q FAW_PDA_EBA |x Aggregator |3 Volltext | |
| 966 | e | |u http://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&AN=500681 |l FAW02 |p ZDB-4-EBA |q FAW_PDA_EBA |x Aggregator |3 Volltext | |
Datensatz im Suchindex
| _version_ | 1804176918476488704 |
|---|---|
| any_adam_object | |
| building | Verbundindex |
| bvnumber | BV043961047 |
| collection | ZDB-4-EBA |
| ctrlnum | (ZDB-4-EBA)ocn708569317 (OCoLC)708569317 (DE-599)BVBBV043961047 |
| dewey-full | 616.8 |
| dewey-hundreds | 600 - Technology (Applied sciences) |
| dewey-ones | 616 - Diseases |
| dewey-raw | 616.8 |
| dewey-search | 616.8 |
| dewey-sort | 3616.8 |
| dewey-tens | 610 - Medicine and health |
| discipline | Medizin |
| format | Electronic eBook |
| fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>04284nmm a2200529zc 4500</leader><controlfield tag="001">BV043961047</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">00000000000000.0</controlfield><controlfield tag="007">cr|uuu---uuuuu</controlfield><controlfield tag="008">161213s2011 |||| o||u| ||||||eng d</controlfield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9781608051328</subfield><subfield code="9">978-1-60805-132-8</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">1608051323</subfield><subfield code="9">1-60805-132-3</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ZDB-4-EBA)ocn708569317</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)708569317</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV043961047</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">aacr</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-1047</subfield><subfield code="a">DE-1046</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">616.8</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Anastin and malignant gliomas</subfield><subfield code="c">editor, Thomas C. Chen ; co-editor, Marc Chamberlain</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">[Place of publication not identified]</subfield><subfield code="b">Bentham e Books</subfield><subfield code="c">[2011]</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">vii, 195 pages</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="490" ind1="0" ind2=" "><subfield code="a">Controversies in Neuro-Oncology, 1</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">Includes bibliographical references and indexes</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">01 Cover Page.pdf; 02 Title Page; 03 eBooks End User License Agreement-Website; 04 table of contents; 05 Foreword; 06 PREFACE-Avastin; 07 Contributors; 08 Part 1 BASIC SCIENCE AND RATIONALE; 09 Ch-1; 10 Part 2; 11 Ch-2 Desjardins-Avastin-recurrent-chen; 12 Ch-3 kreisl-Avastin_and_Mailgnant_Gliomas_-_Is_there_a_role[1]-chen; 13 Ch-4 GutinRT-_bev_review_FI_PG_9-22[1]-chen; 14 Ch-5 norden_controversies_6-19-09[1]-chen; 15 Part 3; 16 Ch-6 Reardon_chapter_8[1].29; 17 Ch-7 Mehta-radiationControversies_in_Neuro-Avastin-final[1]-chen</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">18 Ch-8 Gilbert-Bevacizumab_and_Malignant_Glioma_final_version_9-14-09[1]-Gilbert-chen19 Part 4; 20 Ch-9 Schiff-Avastin toxicityFinal-Bevacizumab_Toxicity_in_Glioblastoma_with_DS_edits_090109-for_review_11[1]-chen corrected; 21 Ch-10 Rogers Chapter_-_Avastin_and_AC_-_Chamberlain_11-2-09__3_[2]-Chen; 22 Part 5; 23 Ch-11 Raizer- AvastinFinal__2_[1]-chen; 24 Part 6; 25 Ch-12 POPE_GBM_Avastin_Imaging[1]-chen; 26 Ch-13 Butowski-radiographic responses 2-chen; 27 Ch-14 Imaging Responses of Bevacizuma; 28 Ch-15 HENSON091509cleanref[1]-chen; 29 Part 7; 30 Ch-16 Aghi-_Avastin_v2[1]-Chen</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">31 Ch-17 Vogelbaum-Surgical Implications-Avastin_Final[1]-chen32 Part 8; 33 Ch-18 chamberlain-BevNovelApplications_8_6_09[1]-chen; 34 Ch-19 Levin-Radiation_necrosis-082509-Final[1]-chen; 35 Ch-20 chamberlain-salvage-chen; 36 Part 9; 37 Ch-21 StuppBev_rec_glioma__final[1]-chen; 38 Ch-22 van den Bent-Avastin in Europe-chen; 39 Ch-23 Avastin_Weller_2009-6-30[1]-chen; 40 Ch-24 Wick European pers-chen; 41 Part 10; 42 Ch-25 Sunitinib_ebook_chapter___B_Neyns[1]-chen; 43 Ch-26 nabors-cilengitide-chen; 44 Ch-27 SorafenibChapter_FINAL[2]-chen; 45 Ch-28 Wen-VEGF-trap_8-14-09_FINAL[1]-chen</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">46 Ch-29 Batchelor-Gerstner-Dietrich-Cediranib-09-12-09[1]-chen47 Part 11 Conclusion; 48 Ch-30 Gu Development_of_Bevacizumab[1][1]-chen; 49 Author Index -Avastin; 50 Index-final-chen</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">Neuro-oncology is an embryonic field of cancer research with a number of clinical trials in progress. However, the prognosis on neuro-oncologic patients has remained poor. Moreover, several small scale phase I/II trials performed have proved to be inconclusive because of the limited number of patients involved. As a result, many controversies exist in neuro-oncology drug development for which a forum does not exist. This ebook presents a detailed account on the use of avastin in treating cancer patients. A discussion on clinical experiences and the controversial debate among researchers of ava</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Neurology / Miscellanea</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Neurology</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">HEALTH & FITNESS / Diseases / Nervous System (incl. Brain)</subfield><subfield code="2">bisacsh</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">MEDICAL / Neurology</subfield><subfield code="2">bisacsh</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Bevacizumab</subfield><subfield code="2">fast</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Gliomas</subfield><subfield code="2">fast</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Medizin</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Gliomas</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Bevacizumab</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Chen, Thomas C.</subfield><subfield code="e">Sonstige</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Chamberlain, Marc C.</subfield><subfield code="e">Sonstige</subfield><subfield code="4">oth</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">ZDB-4-EBA</subfield></datafield><datafield tag="999" ind1=" " ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-029369751</subfield></datafield><datafield tag="966" ind1="e" ind2=" "><subfield code="u">http://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&AN=500681</subfield><subfield code="l">FAW01</subfield><subfield code="p">ZDB-4-EBA</subfield><subfield code="q">FAW_PDA_EBA</subfield><subfield code="x">Aggregator</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="966" ind1="e" ind2=" "><subfield code="u">http://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&AN=500681</subfield><subfield code="l">FAW02</subfield><subfield code="p">ZDB-4-EBA</subfield><subfield code="q">FAW_PDA_EBA</subfield><subfield code="x">Aggregator</subfield><subfield code="3">Volltext</subfield></datafield></record></collection> |
| id | DE-604.BV043961047 |
| illustrated | Not Illustrated |
| indexdate | 2024-07-10T07:39:49Z |
| institution | BVB |
| isbn | 9781608051328 1608051323 |
| language | English |
| oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-029369751 |
| oclc_num | 708569317 |
| open_access_boolean | |
| owner | DE-1047 DE-1046 |
| owner_facet | DE-1047 DE-1046 |
| physical | vii, 195 pages |
| psigel | ZDB-4-EBA ZDB-4-EBA FAW_PDA_EBA |
| publishDate | 2011 |
| publishDateSearch | 2011 |
| publishDateSort | 2011 |
| publisher | Bentham e Books |
| record_format | marc |
| series2 | Controversies in Neuro-Oncology, 1 |
| spelling | Anastin and malignant gliomas editor, Thomas C. Chen ; co-editor, Marc Chamberlain [Place of publication not identified] Bentham e Books [2011] vii, 195 pages txt rdacontent c rdamedia cr rdacarrier Controversies in Neuro-Oncology, 1 Includes bibliographical references and indexes 01 Cover Page.pdf; 02 Title Page; 03 eBooks End User License Agreement-Website; 04 table of contents; 05 Foreword; 06 PREFACE-Avastin; 07 Contributors; 08 Part 1 BASIC SCIENCE AND RATIONALE; 09 Ch-1; 10 Part 2; 11 Ch-2 Desjardins-Avastin-recurrent-chen; 12 Ch-3 kreisl-Avastin_and_Mailgnant_Gliomas_-_Is_there_a_role[1]-chen; 13 Ch-4 GutinRT-_bev_review_FI_PG_9-22[1]-chen; 14 Ch-5 norden_controversies_6-19-09[1]-chen; 15 Part 3; 16 Ch-6 Reardon_chapter_8[1].29; 17 Ch-7 Mehta-radiationControversies_in_Neuro-Avastin-final[1]-chen 18 Ch-8 Gilbert-Bevacizumab_and_Malignant_Glioma_final_version_9-14-09[1]-Gilbert-chen19 Part 4; 20 Ch-9 Schiff-Avastin toxicityFinal-Bevacizumab_Toxicity_in_Glioblastoma_with_DS_edits_090109-for_review_11[1]-chen corrected; 21 Ch-10 Rogers Chapter_-_Avastin_and_AC_-_Chamberlain_11-2-09__3_[2]-Chen; 22 Part 5; 23 Ch-11 Raizer- AvastinFinal__2_[1]-chen; 24 Part 6; 25 Ch-12 POPE_GBM_Avastin_Imaging[1]-chen; 26 Ch-13 Butowski-radiographic responses 2-chen; 27 Ch-14 Imaging Responses of Bevacizuma; 28 Ch-15 HENSON091509cleanref[1]-chen; 29 Part 7; 30 Ch-16 Aghi-_Avastin_v2[1]-Chen 31 Ch-17 Vogelbaum-Surgical Implications-Avastin_Final[1]-chen32 Part 8; 33 Ch-18 chamberlain-BevNovelApplications_8_6_09[1]-chen; 34 Ch-19 Levin-Radiation_necrosis-082509-Final[1]-chen; 35 Ch-20 chamberlain-salvage-chen; 36 Part 9; 37 Ch-21 StuppBev_rec_glioma__final[1]-chen; 38 Ch-22 van den Bent-Avastin in Europe-chen; 39 Ch-23 Avastin_Weller_2009-6-30[1]-chen; 40 Ch-24 Wick European pers-chen; 41 Part 10; 42 Ch-25 Sunitinib_ebook_chapter___B_Neyns[1]-chen; 43 Ch-26 nabors-cilengitide-chen; 44 Ch-27 SorafenibChapter_FINAL[2]-chen; 45 Ch-28 Wen-VEGF-trap_8-14-09_FINAL[1]-chen 46 Ch-29 Batchelor-Gerstner-Dietrich-Cediranib-09-12-09[1]-chen47 Part 11 Conclusion; 48 Ch-30 Gu Development_of_Bevacizumab[1][1]-chen; 49 Author Index -Avastin; 50 Index-final-chen Neuro-oncology is an embryonic field of cancer research with a number of clinical trials in progress. However, the prognosis on neuro-oncologic patients has remained poor. Moreover, several small scale phase I/II trials performed have proved to be inconclusive because of the limited number of patients involved. As a result, many controversies exist in neuro-oncology drug development for which a forum does not exist. This ebook presents a detailed account on the use of avastin in treating cancer patients. A discussion on clinical experiences and the controversial debate among researchers of ava Neurology / Miscellanea Neurology HEALTH & FITNESS / Diseases / Nervous System (incl. Brain) bisacsh MEDICAL / Neurology bisacsh Bevacizumab fast Gliomas fast Medizin Gliomas Bevacizumab Chen, Thomas C. Sonstige oth Chamberlain, Marc C. Sonstige oth |
| spellingShingle | Anastin and malignant gliomas Neurology / Miscellanea Neurology HEALTH & FITNESS / Diseases / Nervous System (incl. Brain) bisacsh MEDICAL / Neurology bisacsh Bevacizumab fast Gliomas fast Medizin Gliomas Bevacizumab |
| title | Anastin and malignant gliomas |
| title_auth | Anastin and malignant gliomas |
| title_exact_search | Anastin and malignant gliomas |
| title_full | Anastin and malignant gliomas editor, Thomas C. Chen ; co-editor, Marc Chamberlain |
| title_fullStr | Anastin and malignant gliomas editor, Thomas C. Chen ; co-editor, Marc Chamberlain |
| title_full_unstemmed | Anastin and malignant gliomas editor, Thomas C. Chen ; co-editor, Marc Chamberlain |
| title_short | Anastin and malignant gliomas |
| title_sort | anastin and malignant gliomas |
| topic | Neurology / Miscellanea Neurology HEALTH & FITNESS / Diseases / Nervous System (incl. Brain) bisacsh MEDICAL / Neurology bisacsh Bevacizumab fast Gliomas fast Medizin Gliomas Bevacizumab |
| topic_facet | Neurology / Miscellanea Neurology HEALTH & FITNESS / Diseases / Nervous System (incl. Brain) MEDICAL / Neurology Bevacizumab Gliomas Medizin |
| work_keys_str_mv | AT chenthomasc anastinandmalignantgliomas AT chamberlainmarcc anastinandmalignantgliomas |